Weiyue Lu Selected Research

Adenocarcinoma

10/2020	Guanidyl and imidazolyl integration group-modified PAMAM for gastric adenocarcinoma gene therapy.
8/2015	D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiyue Lu Research Topics

Disease

82	Neoplasms (Cancer) 04/2024 - 02/2008
43	Glioma (Gliomas) 04/2024 - 09/2012
25	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 04/2010
21	Brain Neoplasms (Brain Tumor) 04/2024 - 07/2011
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2010
7	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2017
4	Fibrosis (Cirrhosis) 09/2020 - 09/2011
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2023 - 08/2021
3	Retinoblastoma (Glioblastoma, Retinal) 02/2023 - 11/2019
3	Triple Negative Breast Neoplasms 01/2023 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 10/2017
3	Hemolysis 07/2019 - 10/2008
3	Laryngeal Neoplasms (Laryngeal Cancer) 07/2015 - 10/2009
2	Dry Eye Syndromes (Dry Eye Syndrome) 05/2024 - 03/2014
2	Thrombosis (Thrombus) 04/2022 - 12/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2015
2	Lung Neoplasms (Lung Cancer) 10/2020 - 01/2017
2	Adenocarcinoma 10/2020 - 08/2015
2	Anaphylaxis (Anaphylactic Shock) 01/2020 - 10/2019
2	Melanoma (Melanoma, Malignant) 04/2019 - 01/2016
2	Necrosis 01/2019 - 02/2008
2	Bacterial Infections (Bacterial Infection) 09/2017 - 03/2016
2	Infections 03/2016 - 06/2015
2	Lymphatic Metastasis 06/2015 - 10/2011

Drug/Important Bio-Agent (IBA)

51	Peptides (Polypeptides)IBA 04/2024 - 01/2010
34	LigandsIBA 03/2023 - 10/2011
30	Liposomes (Liposome)IBA 01/2022 - 02/2008
21	MicellesIBA 01/2020 - 05/2009
20	Paclitaxel (Taxol)FDA LinkGeneric 08/2021 - 10/2009
19	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 02/2008
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2011
10	IntegrinsIBA 01/2021 - 09/2011
9	Neuropilin-1IBA 09/2018 - 10/2013
8	cyclic arginine-glycine-aspartic acid peptideIBA 01/2020 - 04/2010
8	PolyethyleneimineIBA 08/2015 - 08/2011
7	PolymersIBA 10/2020 - 01/2005
7	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 08/2015 - 08/2011
6	Endoplasmic Reticulum Chaperone BiPIBA 04/2024 - 10/2017
6	monomethoxypolyethylene glycol (MPEG)IBA 07/2015 - 05/2009
5	LipidsIBA 05/2024 - 04/2016
5	Gemcitabine FDA Link 04/2024 - 01/2015
5	Small Interfering RNA (siRNA)IBA 02/2023 - 01/2018
5	polypeptide CIBA 01/2021 - 04/2010
5	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 01/2020 - 04/2010
5	Nanoparticle Drug Delivery SystemIBA 03/2018 - 06/2012
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 06/2016
5	Ethylene Glycol (Monoethylene Glycol)IBA 06/2015 - 04/2010
4	Folic Acid (Vitamin M)FDA LinkGeneric 07/2022 - 05/2009
4	Therapeutic UsesIBA 01/2022 - 10/2013
4	polyethylene glycol- distearoylphosphatidylethanolamineIBA 10/2017 - 05/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2011
3	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 12/2019
3	Docetaxel (Taxotere)FDA Link 03/2024 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2022 - 09/2011
3	Cell-Penetrating PeptidesIBA 01/2022 - 01/2016
3	Temozolomide (Temodar)FDA LinkGeneric 10/2021 - 11/2015
3	AntibodiesIBA 01/2021 - 12/2016
3	Nicotine FDA Link 11/2020 - 11/2015
3	Cholinergic ReceptorsIBA 11/2020 - 11/2015
3	poly(gamma-glutamylglutamine)paclitaxelIBA 11/2017 - 01/2017
3	CarbonIBA 10/2017 - 12/2015
3	ErbB Receptors (EGF Receptor)IBA 07/2017 - 01/2015
2	SolutionsIBA 04/2024 - 12/2015
2	NucleosidesIBA 04/2024 - 10/2018
2	Dopamine Receptors (Dopamine Receptor)IBA 04/2024 - 09/2017
2	VaccinesIBA 11/2023 - 03/2016
2	penetratinIBA 02/2023 - 08/2017
2	cabazitaxel FDA Link 01/2022 - 01/2022
2	HydrogelsIBA 10/2021 - 06/2015
2	Immunoglobulin G (IgG)IBA 01/2021 - 10/2019
2	Immunoglobulin M (IgM)IBA 01/2021 - 10/2020
2	Immune Checkpoint InhibitorsIBA 10/2020 - 04/2019
2	phenolic acidIBA 10/2020 - 09/2017
2	Antisense OligonucleotidesIBA 09/2020 - 08/2017
2	Drug CarriersIBA 01/2020 - 04/2016
2	GlycopeptidesIBA 07/2019 - 01/2018
2	Melitten (Melittin)IBA 07/2019 - 04/2016
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 10/2018 - 01/2018
2	Myristic Acid (Tetradecanoic Acid)IBA 06/2018 - 10/2011
2	Nucleic AcidsIBA 01/2018 - 01/2018
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2018 - 01/2017
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2018 - 01/2017
2	Contrast MediaIBA 01/2018 - 01/2012
2	RGERPPR peptideIBA 01/2018 - 12/2013
2	Staphylococcal Protein A (Protein A)IBA 01/2018 - 01/2017
2	Gadolinium DTPA (Magnevist)FDA Link 01/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 01/2017
2	Monoclonal AntibodiesIBA 08/2017 - 02/2008
2	Fluorescein (Funduscein)FDA LinkGeneric 04/2016 - 01/2013
2	Tumor Suppressor Protein p53IBA 11/2015 - 04/2012
2	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 06/2015 - 05/2009
2	aspartic acid glycine arginineIBA 06/2012 - 04/2010

Therapy/Procedure

41	Therapeutics 06/2023 - 01/2010
16	Drug Therapy (Chemotherapy) 04/2024 - 10/2009
7	Intravenous Administration 10/2020 - 04/2010
5	Precision Medicine 01/2018 - 01/2017
4	Intravenous Injections 01/2020 - 01/2016
2	Intravaginal Administration 10/2021 - 08/2021
2	Nanospheres 01/2017 - 12/2015
2	Radiotherapy 06/2014 - 10/2009